Biblio
Found 95 results
Author Keyword [ Title] Type Year Filters: Keyword is Alzheimer Disease [Clear All Filters]
“Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.”, Neurogenetics, vol. 5, no. 4, pp. 201-8, 2004.
, “A comprehensive genetic association study of Alzheimer disease in African Americans.”, Arch Neurol, vol. 68, no. 12, pp. 1569-79, 2011.
, “Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus.”, Mol Psychiatry, vol. 11, no. 3, pp. 280-5, 2006.
, “Defining the Genetic Architecture of Alzheimer's Disease: Where Next.”, Neurodegener Dis, vol. 16, no. 1-2, pp. 6-11, 2016.
, “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.
, “Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.”, PLoS Genet, vol. 6, no. 9, p. e1001130, 2010.
, “Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.”, Neurobiol Dis, vol. 21, no. 2, pp. 256-75, 2006.
, “Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.”, Nature, vol. 429, no. 6987, pp. 75-9, 2004.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.”, Hum Mol Genet, vol. 14, no. 3, pp. 447-60, 2005.
, “The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.”, Neurobiol Aging, vol. 41, pp. 115-121, 2016.
, “Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.”, Mol Psychiatry, vol. 9, no. 11, pp. 1042-51, 2004.
, “Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.”, Neurogenetics, vol. 11, no. 3, pp. 335-48, 2010.
, “Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease.”, Neurogenetics, vol. 9, no. 2, pp. 127-38, 2008.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.
, “Genetic association between endothelial nitric oxide synthase and Alzheimer disease.”, Clin Genet, vol. 70, no. 1, pp. 49-56, 2006.
, “Genetic association of low density lipoprotein receptor and Alzheimer's disease.”, Neurobiol Aging, vol. 26, no. 1, pp. 1-7, 2005.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.”, Expert Rev Mol Diagn, vol. 15, no. 3, pp. 339-48, 2015.
, “Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.”, Mol Psychiatry, vol. 20, no. 12, pp. 1588-95, 2015.
, “Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.”, Genome Med, vol. 10, no. 1, p. 43, 2018.
, “Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.”, BMC Res Notes, vol. 7, p. 42, 2014.
, “Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.”, Dement Geriatr Cogn Disord, vol. 45, no. 1-2, pp. 1-17, 2018.
, “Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.”, Nat Genet, vol. 41, no. 2, pp. 192-8, 2009.
,